Chemical formula: C₁₇H₂₀F₆N₂O₃ Molecular mass: 414.343 g/mol PubChem compound: 3356
Flecainide acetate is a Class IC antiarrhythmic agent used for the treatment of severe symptomatic life-threatening ventricular arrhythmias and supraventricular arrhythmias. Electrophysiologically, flecainide is a local anaesthetic-type (Class IC) of antiarrhythmic compound. It is an amide type of local anaesthetic, being structurally related to procainamide and encainide in so far as these agents are also benzamide derivatives.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01BC04 | Flecainide | C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BC Antiarrhythmics, class Ic |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| FLECAINIDE Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Flecainide is an active ingredient of these brands:
Croatia (HR)Cyprus (CY)
Ecuador (EC)
Finland (FI)
France (FR)
Germany (DE)
Hong Kong (HK)
Ireland (IE)
Israel (IL)
Italy (IT)
Japan (JP)
Mexico (MX)
Netherlands (NL)
New Zealand (NZ)
Singapore (SG)
South Africa (ZA)
Tunisia (TN)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
